ReviewFrontiers in immunology2025

New dimensions of PD-1/PD-L1 inhibitor combination therapy in cancer treatment: current advances and future perspectives.

Cheng Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.